About Christina Matthews Conti
Positions
- Clinical Pharmacist Specialist
- Pharmacy Residency Program Coordinator for Clinical Pharmacy Services
- Pharmacy Department
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo
- Adjunct Instructor, Department of Pharmacy Practice
Background
Education and Training:
- 2010-2014 - Doctor of Pharmacy - SUNY University at Buffalo, Buffalo, NY
Residency:
- 2014-2015- Post Graduate Year One Pharmacy Residency, The Ohio State University Wexner Medical Center, Columbus, OH
- 2015-2016 - Post Graduate Year Two Hematology Oncology Residency, The Ohio State University, Columbus, OH
Board Certification:
- Board Certified Oncology Pharmacist
Professional Memberships:
- American Society of Health-System Pharmacists
- Hematology/Oncology Pharmacy Association
Honors & Awards:
- Clifton Latolais "Message to Garcia" Award
Publications
Prescott GM, Matthews CM. Long-acting reversible contraception: a review in special populations. Pharmacotherapy. 2014 Jan;34(1):46-59. doi 10.1002/phar.13583 Epub 2013 Oct 15.
Dhakal A, Matthews CM, Levine EG, Salerno KE, Zhang F, Takabe K, Early AP, Edge SB, O'Connor T, Khoury T, Young JS, Opyrchal M. Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment. Clin Breast Cancer. 2018 Dec;18(6):e1401-e1405. doi: 10.1016/j.clbc.2018.04.015. Epub 2018 Apr 28.
Yucebay F, Matthews C, Puto M, Junan L, Basem W, Jaglowski SM, Penza SM, Vasu S, Benson DM, Andritos LA, Devine SM, Efebera YA, Roddy JVF. Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host disease: analysis of a single-center experience. Leuk Lymphoma. 2019 Sep;60(9):2223-2229. doi: 10.1080/10428194.2019.1573996. Epub 2019 Feb 15.
Matthews CM, Nymberg K, Berger M, Vargo CA, Dempsey J, Li J, Ramaswamy B, Reinbolt R, Sardesai S, Wesolowski R, Williams N, Lustberg M. Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience. J Oncol Pharm Pract. 2020 Apr;26(3):572-579. doi: 10.1177/1078155219857800. Epub 2019 Jun 29.